Clinical pilot study on the development of pelvic malposition diagnosis method for chuna treatment for non-acute low back pai

Not Applicable

• Conditions: Diseases of the musculoskeletal system and connective tissue

• Registration Number: KCT0007480
• Lead Sponsor: Pusan National University Korean Medicine Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 September 2022

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

1. adult lumbosacropelvic patients(aged 19~65) with non-acute low back pain(onset before more than 2 weeks) and Numeric Rating Scale score above 4
2. aged above 19 and below 65
3. Body Mass Index under 30 (standard according to Obesity Clinical Practice Guideline of Korean Society for the Study of Obesity)
4. patient who is capable of ordinary communication
5. participant who has signed the clinical trail consent form with voluntary participation decision

Exclusion Criteria

1. patient with underlying disease which could cause low back pain(vertebral metastasis of tumor, acute fracture and dislocation, polio, etc.)
2. patient with absolute contraindication of Chuna Manual Therapy(acute cauda equina syndrome, vertebral dislocation, cerebral aneurysm, etc.)
3. patient who is considered inappropriate for the clinical trial by researcher(e.g. lumbosacropelvic operation history, knee operation history, innate vertebral disease, nerve root block operation history, etc.)
4. operation or medical procedure is scheduled during the treatment period
5. patient with chronic disease which could affect the effect of the clinical study : cardiovascular disease, kidney disease, diabetic neuropathy, dementia, epilepsy, etc.
6. patient who has received Chuna Manual Therapy within 2 weeks of clinical study registration
7. patient who has participated other clinical trials within 1 month
8. patient who is incapable of ordinary communication because of dementia or mild cognition disorder, etc.
9. pregnant women
10. person who has difficulty with signing the clinical trial consent form or is considered incapable of carrying out the normal clinical trial procedure
* In the case the number of enrollment of group with/without pelvic deviation is satisfied, patient is considered as meeting the exclusion criteria 10.

Study & Design

• Study Type: Observational Study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
3D body type analysis test indicator: height of body surface

Secondary Outcome Measures

Name	Time	Method
3D body type analys test indicator: site of color marker, direction of surface normal vector;X-ray imaging indicator: distance and angle between feature point